NPCE - Neuropace - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NPCE is currently covered by 3 analysts with an average price target of $19.43. This is a potential upside of $7.04 (56.82%) from yesterday's end of day stock price of $12.39.

Neuropace's activity chart (see below) currently has 81 price targets and 75 ratings on display. The stock rating distribution of NPCE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.2% with an average time for these price targets to be met of 171.4 days.

Highest price target for NPCE is $22, Lowest price target is $16, average price target is $19.43.

Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 29-Jul-2026. First documented stock forecast 17-May-2021.

Best performing analysts who are covering NPCE - Neuropace:

Ross Osborn Priya Sachdeva Vik Chopra Yi Chen Mike Polark

Currently out of the existing stock ratings of NPCE, 5 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-May-2025

$20

$7.3 (57.48%)

$20

2 months 9 days ago
(29-Jul-2026)

2/4 (50%)

$6.36 (46.63%)

222

Buy Since 21-Jan-2025

$22

$5.53 (33.58%)

$18

9 months 22 days ago
(16-Dec-2025)

2/3 (66.67%)

$6.12 (38.54%)

221

Buy Since 08-Nov-2023

$20

$3.53 (21.43%)

$16

9 months 28 days ago
(10-Dec-2025)

4/5 (80%)

$3.22 (19.19%)

126

Buy Since 29-May-2024

$16

$-0.47 (-2.85%)

$15

11 months 3 days ago
(05-Nov-2025)

7/10 (70%)

$3.02 (23.27%)

146

Buy Since 10-Nov-2023

$16

$-0.47 (-2.85%)

$16

1 years 29 days ago
(09-Sep-2025)

10/13 (76.92%)

$6.03 (60.48%)

135

Show more analysts

Please expand the browser size to see the chart

What is NPCE (Neuropace) average time for price targets to be met?

On average it took 171 days for the stock forecasts to be reached, with an average price target met ratio of 72.2%.

Which analyst most recently updated their price target on NPCE (Neuropace)?

Yi Chen

Which analyst has the most public recommendations on NPCE (Neuropace)?

Yi Chen works at HC WAINWRIGHT and has 15 price targets and 10 ratings on NPCE

Which analyst is the currently most bullish on NPCE (Neuropace)?

Priya Sachdeva with the highest potential upside of $9.3

Which analyst is the currently most reserved on NPCE (Neuropace)?

Drew Ranieri with the lowest potential downside of -$8.47
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?